Drug | GP responders | OB/GYN responders | p-valuea |
---|---|---|---|
Median & [50 %] and 90 % IPR | Median & [50 %] 90 % IPR | ||
Acetaminophen | 2.0 [1.0â5.0]; 0.4â16 | 2.5 [1.0â4.0]; 0.5â5.0 | 0.41 |
Phenoxymethylpenicillin | 2.0 [1.0â5.0]; 0.1â6.0 | 2.0 [1.0â3.0]; 0,1â5,0 | 0.29 |
Metoclopramide | 3.0 [1.0â5.0]; 0.20â7.0 | 2.0 [1.0â4.0]; 0.5â5.0 | 0.02 |
Citalopram/sertraline | 4.0 [2.0â6.0]; 0.8â10.0 | 3.0 [2.0â5.0]; 0.5â6.0 | 0.02 |
Benzodiazepines | 3.0 [1.0â5.0]; 0.5â8.0 | 2.5 [1.0â4.0]; 0.5â5.0 | 0.03 |
Inhaled glucocorticoids | 3.0 [1.0â5.0]; 0.2â5.5 | 2.0 [1.0â3.0]; 0.5â5.0 | 0.54 |
Fluconazole | 3.0 [1.5â5.0]; 0.5â7.0 | 2.5 [1.1â4.0]; 0.5â6.0 | 0.45 |
Quetiapine | 5.0 [2.0â7.0]; 1.0â10 | 3.0 [1.5â5.0]; 0.5â6.0 | 0.001 |
Lamotrigine | 5.0 [2.1â6.0]; 1.0â12 | 4.0 [2.0â5.0]; 0.6â7.0 | 0.25 |
Thalidomide | 20 [10â50]; 5.0â60 | 20 [9.0â45]; 5.0â50 | 0.14 |
Warfarin | 3.0 [1.5â5.0]; 0.5â10 | 5.0 [2.1â7.0]; 1.0â15 | 0.01 |
Retinoids | 10 [5.0â20]; 1.6â50 | 5.0 [2.1â10]; 1.0â30 | 0.001 |
Background incidence | 2.0 [0.5â4.0]; 0.02â5.0 | 2.0 [1.0â3.0]; 0.03â4.0 | 0.36 |